Fymika 250mg Injection
Marketer
Syntonic Lifesciences
Salt Composition
Amikacin (250mg)
Overview Fymika 250mg Injection
Cefimizole 250mg Injection is a broad-spectrum antibiotic combating diverse bacterial infections. These can encompass urinary tract, bone, and joint infections; respiratory illnesses like pneumonia; and infections affecting the brain, blood, and other sites. Prophylactic use is also indicated in hospitalized individuals. Cefimizole 250mg Injection inhibits bacterial proliferation. Administered intravenously (IV drip) or intramuscularly by a healthcare provider, self-injection is strictly prohibited. Consistent dosing, as directed, is crucial; skipping doses or prematurely halting treatment risks relapse or infection exacerbation. Typical side effects involve injection site reactions and elevated blood urea nitrogen (BUN). Persistent side effects or treatment inefficacy warrant immediate medical attention. High doses may rarely cause vertigo, nephrotoxicity, and ototoxicity. Adherence to prescribed instructions, including regular monitoring of kidney function, hearing, and urine analysis, is essential. This medication is contraindicated during pregnancy and should be disclosed to your physician if pregnant, planning pregnancy, or breastfeeding.
Primary Ingredients of Fymika 250mg Injection
No text provided. Please provide the text you would like me to rephrase.
Uses of Fymika 250mg Injection
Infections caused by bacteria
Major Benefits of Fymika 250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Fymika 250mg Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use Fymika 250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Fymika 250mg Injection works:
Fymika 250mg Injection is a bacterial growth inhibitor, a type of antibiotic medication. Its mechanism of action involves disrupting the production of vital bacterial proteins, thereby halting bacterial replication.
SAFETY ADVICE
AlcoholSAFE
Fymika 250mg Injection can be used concurrently with alcohol without adverse reactions.
PregnancyCONSULT YOUR DOCTOR
Administering Fymika 250mg Injection during pregnancy is contraindicated due to established risks to fetal development. In exceptional circumstances involving life-threatening conditions, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is mandatory.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Fymika, 250mg, poses no known breastfeeding risk. Research in humans indicates minimal drug transfer to breast milk, presenting no discernible harm to infants.
DrivingUNSAFE
Administering Fymika 250mg Injection might reduce attentiveness, impair vision, or induce drowsiness and dizziness. Driving should be avoided if such effects manifest.
KidneyCAUTION
Exercise caution when administering the Fymika 250mg Injection to individuals with impaired renal function. Dosage modification for Fymika 250mg Injection may be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Fymika 250mg Injection in individuals with hepatic impairment is likely safe. Current evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Fymika 250mg Injection :
Should you forget a scheduled dose of the Fymika 250mg injection, seek advice from your physician.
Facts to Know About Fymika 250mg Injection
| Label | Value |
|---|---|
| Chemical Type | Aminoglycoside antibiotics |
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
| Action Class | Aminoglycoside antibiotics |
3,018 People bought this recently